Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement

Clin Exp Allergy. 2022 Jun;52(6):806-811. doi: 10.1111/cea.14137. Epub 2022 May 10.
No abstract available

Keywords: Peanut allergy; health-related quality of life; oral immunotherapy; probiotic and peanut oral immunotherapy; sustained unresponsiveness.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Allergens
  • Arachis / adverse effects
  • Desensitization, Immunologic / adverse effects
  • Humans
  • Immunotherapy
  • Peanut Hypersensitivity* / therapy
  • Probiotics*
  • Quality of Life

Substances

  • Allergens

Associated data

  • ANZCTR/ACTRN12615001275550